The integrin alpha 2 beta 1 (GPIa/IIa)-I-domain inhibits platelet-collagen interaction.
The integrin alpha 2 beta 1 is a major cellular receptor for collagen. The alpha 2 subunit contains an +/- 200 amino acids inserted domain (I-domain) in the N-terminal region. A certain degree of homology exists between the I-domains found in integrins, collagen and the A-domains of vWF. The alpha 2-I-domain encoding region (aa residues D145 to S334) was obtained by RT-PCR from mRNA of non stimulated human PBL's. The primers were designed to introduce the necessary restriction sites for cloning of the DNA fragment in frame downstream of the malE gene, as well as a stop codon after the last triplet. The resulting construct pMAL-c2-alpha 2-I allows the expression of the I-domain, fused to the C-terminus of maltose binding protein (mal). The alpha 2-I-mal is purified from the bacterial extract by affinity chromatography on an amylose column. The purified alpha 2-I-mal has been characterized by ELISA's. The alpha 2-I-mal bound to immobilised collagen type I in a concentration dependent manner and could be blocked by the functional monoclonal anti-alpha 2 beta 1 antibody 6F1. The interaction of alpha 2-I-mal with collagen furthermore is Mg(2+)-dependent since the binding was inhibited in the presence of 10 mM EDTA or 10 mM Ca2+ but sustained in the presence of 10 mM Mg2+. Finally, alpha 2-I-mal itself was able to inhibit adhesion of washed platelets to collagen immobilised on a microtiterplate in a dose-dependent manner (alpha 2-I-mal IC50:0.7 microM) as well as platelet aggregation induced by collagen type I (alpha 2-I-mal IC50:0.7 microM). With these results we could confirm that the alpha 2-I-domain represents the collagen-binding site of alpha 2 beta 1 and we furthermore could indicate that this domain is able to prevent platelet adhesion to collagen and collagen-induced platelet aggregation, pointing to the primordial role of alpha 2-I-mal and hence of alpha 2 beta 1 in platelet-collagen interaction.
Depraetere
H
H
Laboratory for Thrombosis Research, Interdisciplinary Research Center, K. U. Leuven, Kortrijk, Belgium. Hilde.Depraetere@kulak.ac.be
Wille
C
C
Gansemans
Y
Y
Stanssens
P
P
Lauwereys
M
M
Baruch
D
D
De Reys
S
S
Deckmyn
H
H
D000818:Animals; D001426:Bacterial Proteins / Q000096:biosynthesis; D001483:Base Sequence; D001792:Blood Platelets / Q000187:drug effects / Q000502:physiology*; D002352:Carrier Proteins / Q000096:biosynthesis; D003094:Collagen / Q000502:physiology*; D017931:DNA Primers; D006801:Humans; D019012:Integrin beta1 / Q000502:physiology; D016023:Integrins / Q000096:biosynthesis / Q000737:chemistry* / Q000502:physiology*; D007700:Kinetics; D008214:Lymphocytes / Q000276:immunology; D058619:Maltose-Binding Proteins; D008969:Molecular Sequence Data; D010446:Peptide Fragments / Q000494:pharmacology; D010973:Platelet Adhesiveness / Q000187:drug effects; D016133:Polymerase Chain Reaction; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D038981:Receptors, Collagen; D011993:Recombinant Fusion Proteins / Q000096:biosynthesis / Q000494:pharmacology
D001426:Bacterial Proteins; D002352:Carrier Proteins; D017931:DNA Primers; D019012:Integrin beta1; D016023:Integrins; D058619:Maltose-Binding Proteins; D010446:Peptide Fragments; D012333:RNA, Messenger; D038981:Receptors, Collagen; D011993:Recombinant Fusion Proteins; D003094:Collagen